the aid library

LIST OPTIONS

Filter

2614

Sort by:

Direction:

Download (760)

View PDF (1749)

Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2010 global survey

World Health Organization (2012) C_WHO

This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create the infrastructure, policies, surveillance and healt... more

Download (131)

View PDF (165)

Communication toolkit to promote prudent antibiotic use aimed at general public

European Centers for Disease Control and Prevention ECDC (2018) C2

verall strategy and objective of the European Antibiotic Awareness Day The overall objective of the European Antibiotic Awareness Day is to support national activities aimed at raising awareness concerning the proper use of antibiotics so as to maintain the efficacy of antibiotics and avoid the eme... more

Download (98)

View PDF (107)

Interim Infection Prevention and Control Recommendations for Coronavirus Disease 2019 (COVID-19) in Health Care Settings

Ministry of Health, Kenya (2020) C2

Accessed: 02.05.2020 These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu... more

Download (72)

View PDF (137)

Prevention and control of noncommunicable diseases in Kazakhstan. The case for investment

World Health Organization WHO (2019) C_WHO

Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and ... more

Download (190)

View PDF (228)

Monitoring and restricting digital marketing of unhealthy products to children and adolescents

World Health OrganizationEurope (2019) C_WHO

The WHO European Office for the Prevention and Control of Noncommunicable Diseases organized an expert meeting on monitoring of digital marketing of unhealthy products to children and adolescents in June 2018. Based on that meeting, this report aims to provide a tool to support Member States in moni... more

Download (93)

View PDF (121)

Prevention and control of noncommunicable diseases in Turkey - The case for investment

Kontsevaya A, Farrington J, Balcılar M, Ergüder T World Health Organization (2018) C_WHO

Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and di... more

Download (180)

View PDF (136)

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS
recommended

African Union; Africa CDC Centres for Disease Control and Prevention; AMREF; ASLM; et al. (2021) CC

ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr... more

Download (70)

View PDF (105)

Reponse à la pandémie COVID- 19 pour les états membres.

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2020) C1

Mars 2020. Recommendations selon les differentes phases

Download (119)

View PDF (171)

Déclaration relative au vaccin Covishield ainsi que sur le passeport numérique de l’Union européenne (UE) sur le COVID intitulé “Pass vert”

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

Download (90)

View PDF (119)

Prevention and control of noncommunicable diseases in Kyrgyzstan: the case for investment

World Health Organization WHO, Regional Office of Europe (2017) C_WHO

Noncommunicable diseases (‎NCDs)‎ such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp... more

Download (321)

View PDF (248)

Guidance on vaccination and prevention of vaccine-preventable disease outbreaks for countries hosting refugees from Ukraine, April 2022 update

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.

Download (86)

View PDF (783)

Waiting for a success story in prevention, control and treatment of Chagas disease in non-endemic countries

Bartoloni, A. Memorias do Instituto Oswaldo Cruz (2022) CC

Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related and poverty-promoting disease. Although data describe a relevan... more

Download (151)

View PDF (158)

Regional action framework for noncommunicable disease prevention and control in the Western Pacific

World Health Organisation (WHO) (2023) C_WHO

The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (‎NCD)‎ epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination... more

Download (169)

View PDF (150)

Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2021 global survey

World Health Organisation (WHO) (2023) C_WHO

To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ... more

Download (125)

View PDF (336)

Cartographie des rapports nationaux du Partenariat sur la résistance aux antimicrobiens et l'utilisation des antimicrobiens (MAAP) Cameroun

Africa Center for Disease Control and Prevention (2023) CC

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr... more

Download (156)

View PDF (375)

Cartographie des rapports nationaux du Partenariat sur la résistance aux antimicrobiens et l'utilisation des antimicrobiens (MAAP) Gabon

Africa Center for Disease Control and Prevention (2023) CC

Download (246)

View PDF (202)

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

World Health Organization WHO (2023) CC

Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected. Infection prevention and control (IP... more

Download (7)

View PDF (10)

Prevention of Cardiovascular Disease: Guidelines for assessment and management of cardiovascular risk

World Health Organization WHO (2007) C_WHO

Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera... more

Download (39)

View PDF (73)

African Union AMR Landmark Report: Voicing African Priorities on the Active Pandemic

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...020 – 2025, which is tailored to meet the specific needs of African nations through a coordinated approach. While most countries in the region have developed and prioritized National Action Plans (NAPs) to tackle AMR, the overall response remains inadequate given the magnitude of the threat, which endangers human, animal, environmental, aquatic, and plant health. Africa bears a significant burden of infectious diseases, accounting for approximately 95% of malaria deaths, 70% of people living with HIV, and 25% of TB deaths globally. In 2019, AMR was linked to approximately 55,000 deaths from HIV, 30,000 from malaria, and 255,000 overall. Major drivers of AMR in the region include the overuse and misuse of antimicrobials in human and food systems, migration, suboptimal vaccination rates, and environmental contamination from hospital and pharmaceutical effluents. Additionally, there is a lack of access to quality-assured antimicrobials and diagnostics, compounded by inadequate knowledge about AMR. Unlike high-income countries, where indiscriminate antimicrobial use is the primary factor driving AMR, African countries face additional challenges, including a lack of access to clean and safe water, poor Water, Sanitation, and Hygiene (WASH) programs, inadequate infection prevention measures, and suboptimal vaccinations for preventable diseases. One in three hospitals in the region lacks clean, safe running water, and one in eight people defecate openly due to inadequate sanitation. Investments in WASH, infection prevention, and biosecurity could save approximately 700,000 lives annually. Addressing AMR in Africa requires a comprehensive, multi-sectoral approach involving the entire society. Sustainable access to antimicrobials, including antibiotics, vaccines, and therapeutics, is crucial, as lack of access leads to more morbidity and mortality than AMR itself. Support for the region should focus on preventing infections, strengthening health and food systems, developing human resources, ensuring sustainable access to diagnostics and therapeutics, and investing in laboratory infrastructure to support surveillance and data generation. more

Download (26)

View PDF (75)

Mpox Molecular Diagnostic Tests(RT-PCR)

Africa Center for Disease Control and Prevention (2024) CC

On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ... more

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023 recommended

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS
recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended